Genmab — Marts 2017
-
Dælme en spændende nyhed. Har Novod en fod indenfor hos ledelsen eller? Synes generelt Genmab udviser en skuffende kommunikation ift data. Der har aldrig rigtig været en klar udmelding om hvornår NHL-data kom, de blev meldt ud til sidste år på et tidspunkt hvis jeg husker ret
-
Nivolumab Combined With Daratumumab in Patients With Advanced Solid Tumors - in clinicaltrials now https://trialbulletin.com/lib/entry/ct-03098550 https://clinicaltrials.gov/show/NCT03098550
-
Hans poster ligger her - http://meetinglibrary.asco.org/content/144487?media=vm&poster=1
-
Nivolumab was announced in januari already http://ir.genmab.com/releasedetail.cfm?ReleaseID=1006597 but they are now working
on it it seems, so that is great -
http://immunosym.org/daily-news/preclinical-work-suggests-combined-pd-l1-and-cd38-inhibition-may-improve-tumor-response Og denne artikel. At vi ser in human data Mid-2017 er helt nyt
-
kan bedre ses på dette link - http://meetinglibrary.asco.org/content/144487?media=sl
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind